POLY MEDICURE
|
POLY MEDICURE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr | ₹99 Cr |
Adjustment | ₹61 Cr | ₹39 Cr | ₹44 Cr | ₹51 Cr | ₹44 Cr |
Changes In working Capital | ₹-50 Cr | ₹-63 Cr | ₹-61 Cr | ₹-12 Cr | ₹-8.69 Cr |
Cash Flow after changes in Working Capital | ₹249 Cr | ₹171 Cr | ₹163 Cr | ₹164 Cr | ₹134 Cr |
Cash Flow from Operating Activities | ₹191 Cr | ₹123 Cr | ₹119 Cr | ₹128 Cr | ₹106 Cr |
Cash Flow from Investing Activities | ₹-179 Cr | ₹-85 Cr | ₹-436 Cr | ₹-107 Cr | ₹-101 Cr |
Cash Flow from Financing Activities | ₹-13 Cr | ₹-35 Cr | ₹317 Cr | ₹-21 Cr | ₹-5.13 Cr |
Net Cash Inflow / Outflow | ₹-0.70 Cr | ₹2.80 Cr | ₹0.10 Cr | ₹0.54 Cr | ₹0.62 Cr |
Opening Cash & Cash Equivalents | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr | ₹4.32 Cr | ₹3.70 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr | ₹4.32 Cr |
Compare Cashflow Statement of peers of POLY MEDICURE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
POLY MEDICURE | ₹14,689.0 Cr | 5.1% | -3.2% | 67.7% | Stock Analytics | |
PREVEST DENPRO | ₹519.7 Cr | -0.7% | -13.2% | 24.9% | Stock Analytics | |
NURECA | ₹292.4 Cr | -5.6% | -18.7% | -6.7% | Stock Analytics |
POLY MEDICURE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
POLY MEDICURE | 5.1% |
-3.2% |
67.7% |
SENSEX | 0.5% |
1.4% |
23.5% |
You may also like the below Video Courses